David A. Siegel Madrigal Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $52,551 - $266,886	900 New	900 $261,000
Q2 2022 Aug 15, 2022	SELL	$58.04 - $100.2 $173,075 - $298,796	-2,982 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $122,958 - $224,158	-2,200 Reduced 42.45%	2,982 $293,000
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $2.2 Million - $2.9 Million	-30,458 Reduced 85.46%	5,182 $439,000
Q3 2021 Nov 15, 2021	SELL	$78.35 - $105.02 $3.86 Million - $5.18 Million	-49,300 Reduced 58.04%	35,640 $2.84 Million
Q2 2021 Aug 16, 2021	SELL	$97.2 - $137.59 $3 Million - $4.25 Million	-30,900 Reduced 26.67%	84,940 $8.27 Million
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $8.28 Million - $9.55 Million	76,300 Added 192.97%	115,840 $13.6 Million
Q4 2020 Feb 16, 2021	BUY	$110.06 - $133.7 $2.31 Million - $2.81 Million	21,000 Added 113.27%	39,540 $4.4 Million
Q3 2020 Nov 16, 2020	BUY	$99.78 - $124.21 $632,804 - $787,739	6,342 Added 51.99%	18,540 $2.2 Million
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $733,465 - $1.53 Million	12,198 New	12,198 $1.38 Million
Q1 2019 May 15, 2019	SELL	$103.48 - $143.84 $2.04 Million - $2.83 Million	-19,698 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$94.77 - $215.54 $1.12 Million - $2.54 Million	11,789 Added 149.06%	19,698 $2.22 Million
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $145,110 - $210,217	700 Added 9.71%	7,909 $1.69 Million
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $40,620 - $125,559	400 Added 5.87%	7,209 $2.02 Million
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $635,620 - $1.01 Million	6,809 New	6,809 $795,000

Others Institutions Holding MDGL

# of Institutions

296

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$861 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$709 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$705 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$693 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$686 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account